A missing label on Semglee prefilled pens may lead to a mix-up of products or strengths resulting in incorrect administration of insulin. To date, the Company has not received reports of adverse ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a ...

Mylan Pharmaceuticals has issued a voluntary recall of one batch of its 100 units/mL insulin glargine injection pens due to the potential for missing labels, according to a press release from the FDA.

This is Mylan’s third voluntary recall of insulin glargine this year, caused by the potential for the labels to be missing on some prefilled pens. On January 18, Mylan recalled a batch of its ...

is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens which are packaged in cartons of five pens to the consumer level.

Walmart announced Tuesday it will start selling private-label insulin this summer at a much lower price for the lifesaving diabetes drug than branded varieties in vials and pens. The new brand ...

Viatris’ Mylan this week said it was once again recalling a solo batch of insulin glargine injection over the potential for the label to be missing on some prefilled pens. Similar issues cropped ...

Labels on the popular insulin pen used by people with diabetes warn against visually impaired people using pens to measure out and administer their insulin dosage. A pilot study overturns that ...

The insulin will cost about $73 per vial or about $86 for a package of prefilled insulin pens. Savings are reported ... pointed out that “the private label brand had the same quality, same ...

During this training period, all pharmacists and pharmacy technicians were trained how to use, label, dispense, and store the insulin pens. Patient selection. Patients were eligible for study ...

The recalled product does not pertain to the branded interchangeable biosimilar, Semglee (insulin glargine-yfgn). Mylan Pharmaceuticals has voluntarily recalled 1 batch of Insulin Glargine ...